The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.

Saved in:
Bibliographic Details
Title: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.
Authors: Goldstein O; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Shani S; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Gana-Weisz M; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Elkoshi N; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Casey F; Formerly Biogen Inc, Cambridge, MA, USA., Sun YH; Research Data Sciences, Translational Biology, Biogen Inc., Cambridge, MA, USA., Chandratre K; Research Data Sciences, Translational Biology, Biogen Inc., Cambridge, MA, USA., Cedarbaum JM; Formerly Biogen Inc, Cambridge, MA, USA.; Department of Neurology, Yale School of Medicine, New Haven, CT, USA., Blauwendraat C; Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA., Bar-Shira A; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Thaler A; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Gurevich T; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Mirelman A; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Giladi N; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Brain Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Orr-Urtreger A; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Alcalay RN; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Source: Journal of Parkinson's disease [J Parkinsons Dis] 2025 Mar; Vol. 15 (2), pp. 291-299. Date of Electronic Publication: 2025 Jan 17.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-718X (Electronic) Linking ISSN: 18777171 NLM ISO Abbreviation: J Parkinsons Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39973498
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goldstein+O%22">Goldstein O</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Shani+S%22">Shani S</searchLink>; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Gana-Weisz+M%22">Gana-Weisz M</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Elkoshi+N%22">Elkoshi N</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Casey+F%22">Casey F</searchLink>; Formerly Biogen Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+YH%22">Sun YH</searchLink>; Research Data Sciences, Translational Biology, Biogen Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chandratre+K%22">Chandratre K</searchLink>; Research Data Sciences, Translational Biology, Biogen Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cedarbaum+JM%22">Cedarbaum JM</searchLink>; Formerly Biogen Inc, Cambridge, MA, USA.; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Blauwendraat+C%22">Blauwendraat C</searchLink>; Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bar-Shira+A%22">Bar-Shira A</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Thaler+A%22">Thaler A</searchLink>; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Gurevich+T%22">Gurevich T</searchLink>; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Mirelman+A%22">Mirelman A</searchLink>; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Giladi+N%22">Giladi N</searchLink>; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Brain Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Orr-Urtreger+A%22">Orr-Urtreger A</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Alcalay+RN%22">Alcalay RN</searchLink>; Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Movement disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101567362%22">Journal of Parkinson's disease</searchLink> [J Parkinsons Dis] 2025 Mar; Vol. 15 (2), pp. 291-299. <i>Date of Electronic Publication: </i>2025 Jan 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101567362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1877-718X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218777171%22">18777171 </searchLink><i>NLM ISO Abbreviation: </i>J Parkinsons Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39973498
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1877718X241310722
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 291
    Titles:
      – TitleFull: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goldstein O
      – PersonEntity:
          Name:
            NameFull: Shani S
      – PersonEntity:
          Name:
            NameFull: Gana-Weisz M
      – PersonEntity:
          Name:
            NameFull: Elkoshi N
      – PersonEntity:
          Name:
            NameFull: Casey F
      – PersonEntity:
          Name:
            NameFull: Sun YH
      – PersonEntity:
          Name:
            NameFull: Chandratre K
      – PersonEntity:
          Name:
            NameFull: Cedarbaum JM
      – PersonEntity:
          Name:
            NameFull: Blauwendraat C
      – PersonEntity:
          Name:
            NameFull: Bar-Shira A
      – PersonEntity:
          Name:
            NameFull: Thaler A
      – PersonEntity:
          Name:
            NameFull: Gurevich T
      – PersonEntity:
          Name:
            NameFull: Mirelman A
      – PersonEntity:
          Name:
            NameFull: Giladi N
      – PersonEntity:
          Name:
            NameFull: Orr-Urtreger A
      – PersonEntity:
          Name:
            NameFull: Alcalay RN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1877-718X
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of Parkinson's disease
              Type: main
ResultId 1